Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis

ASIDE Gastroenterology · Published 2026-07-27 · DOI 10.71079/aside.gi.072726751

Free full text

Authors (7)

Hatem Ahmed, Imad Alabdul Razzak, Iyiad Alabdul Razzak, Sameh Gomaa, Motaz Almahmood, Khloud Abdelrazeq, Joelle Lauchner

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ahmed, H., Razzak, I., Razzak, I., et al. (2026). Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis. ASIDE Gastroenterology. https://doi.org/10.71079/aside.gi.072726751

Related articles